Hearts & Minds Blog

The History of LDL-Cholesterol with Dr. Antonio Gotto

Antonio M. Gotto, Jr., MD, DPhil

Dean Emeritus and Co-Chair of Board of Overseers, Weill Cornell Medical College

Tim Mayleben

President and Chief Executive Officer

As you know, Esperion is focused on developing and commercializing therapies for the treatment of patients with hypercholesterolemia who are not adequately controlled by currently available lipid-modifying therapies. Like any medical innovation, the journey of bempedoic acid started long before Esperion with the earliest identification of LDL-cholesterol (LDL-C) more than a century ago. So as National Cholesterol Education Month recently came to a close, we thought this would be an appropriate time to break down the history of LDL-C lowering. Today, research and understanding of… more

Highlights from the 2016 ESC Congress

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Tim Mayleben

President and Chief Executive Officer

Buongiorno from the ESC Congress! Earlier this week we had the opportunity to attend the 2016 European Society of Cardiology (ESC) Congress in Rome. ESC has become the largest cardiology meeting in the world with more than 32,000 physicians and other healthcare care professionals in attendance this year. This is one of the most important scientific events of the year for cardiovascular disease research, particularly for those focused on developing drugs to help patients around the world lower their levels of LDL-cholesterol. Key highlights we… more

Olympic Reflection: Team USA and Team Esperion

Tim Mayleben

President and Chief Executive Officer

Perhaps, like me, you’ve been watching the Rio 2016 Summer Olympic Games, reading about the Olympics online and in print, and talking about the Olympics with friends and co-workers.  The Olympics have been exciting to watch – and exhausting to keep up with!  Dawn now considers herself an “Olympics widow”. There are always inspiring Olympic storylines but one relatively under-reported story in particular caught my attention. While women represent 51 percent of the US population, did you know that for the second straight Summer Olympics,… more

Raison d’ etre

Tim Mayleben

President and Chief Executive Officer

“The most important reason or purpose for someone or something’s existence.” Bonjour le tout, I am writing to you following a trip to Paris, France with my wife, Dawn, late last month.  Visiting Paris had been on Dawn’s “bucket-list” for many years, and we took advantage of the little time we have together and did all of the things that first-time visitors to Paris do.  On our last night we climbed the stairs of the Arc de Triomphe for what we were told would be… more

Note from our CEO

Tim Mayleben

President and Chief Executive Officer

This is Tim Mayleben – CEO of Esperion Therapeutics with some thoughts I wanted to share.  Please read on if you’re interested. First, a little history.  Esperion Therapeutics was founded by my good friend and colleague, Roger Newton.  You may remember that Roger was the co-discoverer and product champion for Lipitor, the best-selling LDL-cholesterol lowering drug in history (+$125 billion in worldwide revenue and counting).  He was also the founder and CEO of the original Esperion.  I was COO and CFO there.  Roger and I… more